Patent classifications
A61M2205/3576
Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m.sup.2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.
CONTROL FOR RESPIRATORY DEVICE
- Guohua Bao ,
- Venkata Subbarao Potharaju ,
- Arjen David Kat ,
- Gavin Andrew Bryson Ryan ,
- Ian Patrick Sarsfield Hickey ,
- Benjamin Wilson Casse ,
- Sujeewa Wannigama ,
- Gregory Martyn Smith ,
- Nordyn Alami ,
- Nimansha Budhiraja ,
- Donald Roy Kuriger ,
- Adam John Darby ,
- Bernhard Florian Lamprecht ,
- Jeremy Livingston Miller ,
- Johannes Nicolaas Bothma ,
- Dean Antony Barker ,
- Quinton Michael Smith ,
- Emma Louise Nasimi ,
- Andrew Jun Li ,
- Nicholas Edward Vaughan ,
- Zarin Kasad
The operational parameters of a respiratory apparatus can be controlled through the use of a user interface located on a separate or separable mobile computing device. Sensors or features located on the mobile computing apparatus can be used to adjust the operation parameters or therapy of the respiratory apparatus or otherwise improve the compliance of a patient utilizing the respiratory apparatus.
Medicament delivery device
The present invention relates to a medicament delivery device comprising a housing (10), which housing is arranged to accommodate a medicament container (20); a power unit (88) comprising: a drive force element (98), an actuation unit (90, 102) operably connected to said drive force element (98); which actuation unit (90, 102) is movable, upon activation of said drive force element (98), for expelling a dose of medicament from said medicament container (20); a monitoring unit (130) provided with an electrical power source (140) for operating said monitoring unit (130). The invention is characterised in that the medicament delivery device further comprises an activation element (160) operably connected to said actuation unit (90, 102), to said monitoring unit (130) and to said electrical power source (140), wherein said activation element (160) is arranged to allow connection between said electrical power source (140) and said monitoring unit (130) when said actuation unit (98, 102) is moved.
Fluid delivery systems and methods
A method of dispensing fluid includes three processes. A first one of these processes includes pumping fluid into a resilient variable-volume dispensing chamber. The dispensing chamber is in series with a normally present finite fluid impedance and an output. The impedance is sufficient so as to cause expansion of the dispensing chamber as it receives pumped fluid even while some fluid flows through the output. Another one of these processes includes repeatedly measuring a parameter related to volume of the dispensing chamber over time. A third one of these processes includes controlling the pumping of fluid based on repeated measurements of the parameter to produce a desired fluid flow through the output. A corresponding system for dispensing fluid implements these processes.
Model-based infusion site monitor
A medication delivery monitoring device is disclosed. The device includes a user interface configured to receive input information, and a sensor configured to measure a plurality of fluid state parameters of a fluid delivery channel through which the medication is delivered by a vascular access device (VAD) to an infusion site region of the patient. The device also includes a processor configured to determine a state of the infusion site region based on the plurality of measured fluid state parameters and the input information, and an output device configured to provide a communication regarding the state of the infusion site region. Methods and computer-readable mediums for monitoring medication delivery are also disclosed.
Control architecture for reduced pressure wound therapy apparatus
Embodiments of a reduced pressure system and methods for operating the system are disclosed. In some embodiments, the system can include one or more processors responsible for various functions associated with various levels of responsiveness, such as interfacing with a user, controlling a vacuum pump, providing network connectivity, etc. The system can present GUI screens for controlling and monitoring its operation. The system can determine and monitor flow of fluid in the system by utilizing one or more of the following: monitoring the speed of a pump motor, monitoring flow of fluid in a portion of a fluid flow path by using a calibrated fluid flow restrictor, and monitoring one or more characteristics of the pressure pulses. The system can provide external connectivity for accomplishing various activities, such as location tracking of the system, compliance monitoring, tracking of operational data, remote selection and adjustment of therapy settings, etc.
Advance diagnosis of operating mode viability
Techniques related to advance diagnosis of operating mode viability are disclosed. The techniques may involve obtaining status information pertaining to operation of a fluid delivery device. The status information may include at least one of a group comprising recent sensor measurement data, sensor calibration data, blood glucose reference measurement data, fluid delivery data, a current battery level of the fluid delivery device, and a current amount of fluid remaining in the fluid delivery device. The techniques may further involve determining, based on the status information, viability of transitioning to a destination operating mode of the fluid delivery device. Additionally, the techniques may involve causing generation of one or more user notifications of recommended remedial actions to improve the viability of transitioning to the destination operating mode when transitioning into the destination operating mode is determined not to be viable.
Tracheotomy device and method of use
A device for performing a tracheotomy on a patient without the assistance of a medical professional. The device may include one or more mechanical arms that cause a blade to create an incision, cause a dilating tool to dilate the incision, and cause a tracheotomy tube to be inserted into the incision. The device may further include a scanner and/or a hollow needle connected to an air pressure sensor that may be used to detect whether the device is aligned with the patient's airway.
INJECTION DEVICE
Injection monitoring circuitry is provided for coupling to part of an injection device having a syringe and a plunger rod. The injection monitoring circuitry has an input to receive force measurement data from a force sensor, the force measurement data includes a plurality of timestamped force measurements of force applied by a user to the injection device when an injection is administered to an injection site. Processing circuitry is provided to determine from the force measurement data when an end of injection has been reached, the end of injection corresponding to the plunger rod having reached an end position in a distal portion of the barrel of the syringe during administration of the injection by the user. Machine readable instructions and an injection monitoring method are also provided.
DEVICE FOR CONTROLLING INJECTION OF MEDICINAL FLUID
Provided is a liquid medication control injection device including a blood glucose measuring unit configured to measure blood glucose of target of injection at least a plurality of times, sequentially, a first liquid medication injection unit configured to inject a first liquid medication containing a component for controlling a decrease in blood glucose of the target of injection to the target of injection, and a second liquid medication injection unit configured to inject a second liquid medication containing a component for controlling an increase in blood glucose of the target of injection, wherein the component of the second liquid medication is different from that of the first liquid medication.